Medical Net, Inc. (TYO:3645)
Japan · Delayed Price · Currency is JPY 230.00
-2.00 (-0.86%)
Nov 2, 2026, 3:30 PM JST
Medical Net Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
| 2,110 | 2,450 | 2,852 | 3,329 | 3,555 | 4,108 | |
Market Cap Growth | -25.61% | -14.09% | -14.31% | -6.36% | -13.47% | -26.09% |
Enterprise Value | 1,625 | 1,844 | 2,850 | 2,897 | 3,230 | 3,560 |
Last Close Price | 230.00 | 265.00 | 313.64 | 360.78 | 382.26 | 450.43 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
PE Ratio | 28.72 | 17.89 | - | 665.73 | 30.65 | 10.70 |
PS Ratio | 0.31 | 0.36 | 0.47 | 0.63 | 0.79 | 1.10 |
PB Ratio | 1.05 | 1.19 | 1.61 | 1.73 | 1.84 | 2.37 |
P/TBV Ratio | 1.39 | 1.56 | 2.22 | 2.30 | 2.21 | 3.34 |
P/FCF Ratio | 23.45 | 27.23 | - | 38.26 | 8.67 | 12.08 |
P/OCF Ratio | 21.53 | 25.01 | - | 27.97 | 8.29 | 12.01 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
EV/Sales Ratio | 0.24 | 0.27 | 0.47 | 0.55 | 0.72 | 0.95 |
EV/EBITDA Ratio | 7.31 | 6.86 | 16.29 | 8.23 | 7.34 | 7.43 |
EV/EBIT Ratio | 11.21 | 9.61 | 28.79 | 9.69 | 8.52 | 7.91 |
EV/FCF Ratio | 18.06 | 20.49 | - | 33.30 | 7.88 | 10.47 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Debt / Equity Ratio | 0.70 | 0.69 | 0.71 | 0.53 | 0.41 | 0.45 |
Debt / EBITDA Ratio | 6.31 | 5.28 | 7.15 | 2.92 | 1.79 | 1.61 |
Debt / FCF Ratio | - | 15.79 | - | 11.83 | 1.92 | 2.27 |
Net Debt / Equity Ratio | -0.28 | -0.26 | -0.12 | -0.26 | -0.38 | -0.21 |
Net Debt / EBITDA Ratio | -2.55 | -1.99 | -1.17 | -1.42 | -1.66 | -0.75 |
Net Debt / FCF Ratio | - | -5.94 | 0.97 | -5.74 | -1.78 | -1.06 |
Asset Turnover | 1.56 | 1.56 | 1.51 | 1.41 | 1.36 | 1.42 |
Inventory Turnover | 13.33 | 13.91 | 15.70 | 20.74 | 21.59 | 28.92 |
Quick Ratio | 1.37 | 1.37 | 1.21 | 1.46 | 1.53 | 1.37 |
Current Ratio | 1.64 | 1.65 | 1.53 | 1.75 | 1.71 | 1.60 |
Return on Equity (ROE) | 4.88% | 8.46% | -2.06% | 1.30% | 5.95% | 26.64% |
Return on Assets (ROA) | 2.10% | 2.77% | 1.53% | 5.01% | 7.16% | 10.69% |
Return on Invested Capital (ROIC) | 5.46% | 7.80% | -10.47% | 3.76% | 12.83% | 31.18% |
Return on Capital Employed (ROCE) | 6.30% | 8.10% | 4.60% | 12.60% | 18.70% | 24.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Earnings Yield | 3.48% | 5.59% | -2.38% | 0.15% | 3.26% | 9.35% |
FCF Yield | 4.26% | 3.67% | -7.40% | 2.61% | 11.53% | 8.28% |
Dividend Yield | 1.30% | 1.13% | 0.92% | 0.81% | 0.64% | 0.54% |
Payout Ratio | 37.46% | 18.98% | - | 440.00% | 30.17% | 8.85% |
Buyback Yield / Dilution | -3.69% | -2.97% | 1.34% | -0.94% | -2.40% | -3.65% |
Total Shareholder Return | -2.39% | -1.83% | 2.25% | -0.13% | -1.77% | -3.11% |